Protagonist Therapeutics, Inc (NASDAQ:PTGX) has 303 institutional investors that have filed 13F reports for the period ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 9,779,369 | 63,370 | 0.65% | $1,030,745,507.00 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 31 Mar, 2026 | 6,348,906 | 204,900 | 3.33% | $669,174,692.00 |
| Janus Henderson Group Plc | 31 Mar, 2026 | 5,783,054 | 3,133,073 | 118.23% | $609,732,848.00 |
| UBS Group AG | 31 Mar, 2026 | 5,177,796 | 2,407,775 | 86.92% | $545,739,698.00 |
| RTW INVESTMENTS, LP | 31 Mar, 2026 | 5,059,053 | 0 | 0.00% | $533,224,186.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Mar, 2026 | 3,599,644 | 428,221 | 13.50% | $379,402,479.00 |
| State Street Corp | 31 Mar, 2026 | 3,116,749 | -82,980 | -2.59% | $328,505,345.00 |
| Johnson & Johnson | 31 Mar, 2026 | 2,449,183 | -2,449,183 | -50.00% | $258,143,888.00 |
| Invesco Ltd. | 31 Mar, 2026 | 2,164,670 | 596,830 | 38.07% | $228,156,218.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 1,669,371 | 216,443 | 14.90% | $175,982,148.00 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 31 Mar, 2026 | 1,665,497 | 1,665,497 | 0.00% | $175,545.00 |
| CITADEL ADVISORS LLC | 31 Mar, 2026 | 1,551,900 | 425,213 | 37.74% | $163,570,260.00 |
| Woodline Partners LP | 31 Mar, 2026 | 1,414,173 | 5,401 | 0.38% | $149,053,834.00 |
| Bank Of America Corp /De/ | 31 Mar, 2026 | 1,295,434 | 427,854 | 49.32% | $136,538,743.00 |
| PERCEPTIVE ADVISORS LLC | 31 Mar, 2026 | 1,230,879 | -119,546 | -8.85% | $129,734,647.00 |
| JENNISON ASSOCIATES LLC | 31 Mar, 2026 | 1,072,011 | 740,847 | 223.71% | $112,989,961.00 |
| Morgan Stanley | 31 Mar, 2026 | 1,018,222 | 139,198 | 15.84% | $107,320,718.00 |
| ADAR1 Capital Management, LLC | 31 Mar, 2026 | 994,119 | -1,104,217 | -52.62% | $104,780,143.00 |
| Hood River Capital Management LLC | 31 Mar, 2026 | 829,285 | 829,285 | 0.00% | $87,406,639.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 778,945 | -1,143,353 | -59.48% | $82,100,804.00 |